Event Date/Time: Apr 23, 2009 End Date/Time: Apr 24, 2009
Report as Spam



The mapping of the human genome has opened up exciting new possibilities for the development of personalized medicines which have the potential to forever alter the treatment of a variety of human diseases.

Personalized medicine has the potential to revolutionize medical care by utilizing an improved understanding of genetics and molecular biology to allow for better diagnostic tests, more precise diagnoses, greater predictability of disease course, and improved patient safety by selecting not only the right drug for a patient but also the proper dosage to reduce adverse effects.

This conference is being developed in order to bring together the wide variety of stakeholders in both the public and private sector to examine both the opportunities and challenges facing those involved in the development and realization of personalized medicine.

Sessions will be held on variety of topics integral to the development of personalized medicine, including, but not limited to:

* pharmacogenomics
* biomarkers
* molecular diagnostics
* pharmacogenetics

Sessions will not only cover the various scientific and clinical developments in this space, but also a plethora of other issues that will need to be resolved if personalized medicines are to become a reality, including:

* future regulatory models for personalized medicine
* social, ethical and legal concerns
* economic issues (insurance coverage, reimbursement, etc.)

Key Takeaways

* Learn about novel technologies in development which will help lead to the commercialization of personalized medicines
* Hear updates on status of new personalized therapies in development
* Better understand clinical pathways for personalized medicine
* See how molecular diagnostics are being used in tandem with biopharmaceuticals to treat serious health conditions
* Learn more about which therapeutic areas are being targeted for personalized medicine
* See how ground-breaking work in the fields of pharmacogenomics, pharmacogenetics, biomarkers and molecular diagnostics are being funded
* Hear about the clinical, regulatory and commercial strategies that will bring personalized medicine to the forefront of medical care

For more infomation about this conference, please contact us. To enquire about sponsorship and/or exhibiting at this conference please e-mail marketing@arrowheadpublishers.com.

Key Themes

* molecular diagnostics (SNP genotyping, biochip/microarray technologies, optical mapping and biomarkers)
* pharmacogenomics
* pharmacogenetics
* genotyping for drug resistance in HIV, cancer, neurological disorders and other conditions
* bioinformatics
* commercial and economic issues, including, reimbursement, formularies, costs, etc.
* potential regulatory frameworks for personalized medicine
* societal, legal and ethical issues regarding personalized medicine
* investing in personalized medicine

Who Should Attend


* C-Level Officers
* Vice Presidents
* Directors
* Heads
* Managers
* Professors
* Scientists
* Associates
* Students

Practice Areas

* Personalized Medicine
* Pharmacogenomics
* Clinical Research
* Biomarker Development
* Human Genetics
* Molecular Biology
* Genomics
* Proteomics
* Molecular Diagnostics
* Bioinformatics
* Pharmacogenetics
* Regulatory Affairs
* Project Management
* Assay Development
* Clinical Operations

as well as individuals from

* Investment banks
* Private Equity firms
* Venture capital firms
* Consultancies